Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
Sponsor: NYU Langone Health
Summary
The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.
Official title: Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) Trial
Key Details
Gender
MALE
Age Range
40 Years - 95 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-06-17
Completion Date
2028-06-01
Last Updated
2026-07-09
Healthy Volunteers
No
Interventions
Barrigel Injectable Gel
Barrigel is a hyaluronic acid-based absorbable perirectal spacer.
Cryoablation
Minimally invasive treatment for both localized and recurrent prostate cancer.
Locations (1)
NYU Langone Health
New York, New York, United States